Latest clinical trials News | Page 38

World-first preventative DNA screening for cancer and heart disease risk
WHO makes new recommendations for Ebola treatments, calls for improved access
GlyNAC supplementation reverses aging hallmarks in aging humans
NetOptAwario’s new technology transforms detection of heart arrhythmias with AI and remote monitoring
Lynparza in combination with abiraterone granted Priority Review in US for patients with metastatic castration-resistant prostate
Enhertu significantly delayed disease progression in DESTINY-Breast02 Phase III trial vs. physician’s choice of treatment
Enhertu approved in US as first HER2-directed therapy for patients with previously treated HER2-mutant metastatic non-small cell
Brain tumour bank boosts research efforts
CSIRO opens ‘missing link’ lab to developing Australian vaccine pipeline
Breakthrough in precision medicine for treatment of acute myeloid leukaemia
Dietary salt substitutes lower risk of heart attack, stroke and death
Victoria Investing In World-First mRNA Innovation Hub
How long COVID survivors are being sold next round of miracle cures
Enhertu approved in US as first HER2-directed therapy for patients with HER2-low metastatic breast cancer
Calquence tablet formulation approved in US across current indications
Radiopharm Theranostics announces new agreements with Lantheus and NanoMab
What allegations of Alzheimer’s research fraud mean for patients
Critical oncology trial data remains hidden
Tismor Health and Wellness Partner with Health Food Symmetry Ltd
Safety of Covid vaccines in >200,000 Aussie kids: reassuring data from AusVaxSafety
COVID vaccine patch fights variants better than needles
Volunteers needed for high blood pressure and obesity study
Keto therapy clinical trials
Genetic clues to age-related macular degeneration revealed
Activated surface proteins may reverse development of malignant neuroblastoma cells
Enhertu granted Priority Review in US for patients with HER2-low metastatic breast cancer
Novel HIV combination therapies could prevent viral escape and rebound
ANU start-up receives funding for anti-inflammatory research
Training blood vessels may help protect against heart attack, stroke
Enhertu approved in EU for patients with HER2-positive metastatic breast cancer treated with one or more prior anti-HER2-based
Construction begins on $52 million world-class cancer centre & research hub in Sydney’s fastest grow
Sore throats suck. Do throat lozenges help at all?
Discovery boosts hopes of preventing Type I diabetes
New research identifies more effective weapon against blood cancers
UQ accelerates research response to health and medical challenges
NeuroScientific Biopharmaceuticals seeks approval for phase 1 trial
Australia could be first to adopt routine childhood screening for type 1 diabetes
Humans are aggressive, sometimes too much
Use of artificial intelligence to determine cancer recurrence
Dimerix updates with new and positive DMX-700 data
Deadly spider venom treatment for heart attacks reaches next milestone
Novotech secures regional ‘Best Biologics CRO’ award
Mapping ‘energy fingerprints’ of lung cancer leads to fundamental treatment rethink
Mantle cell lymphoma treatment varies according to setting
Hormone-blocking breakthrough helps combat skin cancer recurrence
Interrupting treatment of vulnerable people on immune-suppressing medicines
Lynparza recommended for approval in EU by CHMP as adjuvant treatment for patients with germline BRCA-mutated HER2-negative
Potentially more effective treatment for HER2 mutant metastatic breast cancer